NCT06533436

Brief Summary

The aim of this study is to assess the benefits of using the Anchorfast device in reducing complications associated with intubation tube fixation, in terms of the rate of pressure ulcer development, the rate of intubation tube mobilization and the rate of VAP occurrence. If the hypothesis is confirmed, this project would enable the caregivers to optimize the current practice in the interests of both patients and caregivers. That's why the investigators have designed a real-life study, and will also be looking at the effect of care load on and caregiver satisfaction.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Aug 2024Dec 2026

First Submitted

Initial submission to the registry

February 28, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

August 2, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2026

Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

2 years

First QC Date

February 28, 2024

Last Update Submit

February 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of induced pressure sores

    Evaluate the change in the incidence rate of eschars (grade 1 or higher according to the National Pressure Ulcer Advisory Panel 1998 classification) induced by fixation of the intubation tube with the AnchorFastTM device compared with the cord fixation cord fixation technique.

    16 months

Secondary Outcomes (7)

  • Patient safety regarding the stability of the intubation : number of repositionning

    16 months

  • Patient safety regarding the risk of accidental extubation

    16 months

  • Patient safety regarding ventilator-associated pneumonia

    16 months

  • Patient safety regarding intubation-related complications

    16 months

  • Impact on nursing staff care load

    16 months

  • +2 more secondary outcomes

Study Arms (3)

Cord attachement

ACTIVE COMPARATOR

Caregivers follow the Tensoplast® white cord and elastic plaster fixation protocol, which has been revised and validated by the care department. Tube care is carried out in two stages: preparing the patient for the procedure (safety and hygiene) then renewal of the fixation device.

Procedure: Corded tube care

AnchorFast

EXPERIMENTAL

The AnchorFastTM fixation device developed by Laboratoire Hollister is a single-use medical device. This fixation system consists of a hard plastic guide on which the intubation tube can slide laterally. It facilitate access to the oral cavity and limit pressure points on the corners of the mouth.

Device: Tube care attached by AnchorFast

Caregivers

OTHER

The caregivers will be included as a study population. Caregivers will conduct the search for the other two arms (ancofast and by cord) and then fill in questionnaires assessing the workload and comfort of tube care.

Other: Caregiver's evaluation on each tube fixation

Interventions

The caregiver cut a 6 cm strip of Tensoplast® and wrapped it around the intubation probe at the level of the prescribed fixation mark at the corner of the mouth. The cord strands are placed around the patient's head, tightened, and a double knot is tied at the patient's cheek. Compresses are placed over the ears to protect them from possible lesions caused by the cords.

Cord attachement

Shaving is recommended for patients with beards, and prior family consent is required for patients with beards. AnchorFast is Suitable for intubation probes from 5 to 10 mm in diameter, it adapts to different morphologies thanks to hydrocolloid dressings bonded to the face and an adjustable cord around the neck. Due to its rigidity, this device is not recommended for patients whose condition requires them to be positioned in the ventral decubitus (VD) or lateral decubitus position.

AnchorFast

The caregivers who performs the interventions according to the study will fill question form to assess the worload and the confort of the tube care for each intervention type The caregivers are both a research actor and a study population. One of the secondary aims of this study is to evaluate the two types of tube-fixing with regard to caregiver workload and comfort in performing care. Caregivers will complete identical questionnaires assessing their satisfaction with the two types of tube fixation studied in arms 1 and 2.

Caregivers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years old,
  • Patient with orotracheal intubation,
  • Patient intubated no more than 24 hours previously,
  • Oral consent from patient, trusted support person or relative if unable to consent
  • Membership of a French health insurance scheme.

You may not qualify if:

  • Pre-existing facial, labial or auricular skin lesions,
  • Pre-existing mucositis,
  • Patients extubated for more than 24 hours whose condition requires a new intubation tube
  • Nasotracheal intubation,
  • Planned early tracheotomy,
  • Patient with occipital craniectomy,
  • Patient in ventral position,
  • Pregnant or breast-feeding woman,
  • Patient deprived of liberty or under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Foch

Suresnes, 92150, France

RECRUITING

Study Officials

  • Marisa LAGOA PINTO

    Hôpital Foch

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: A total of 170 patients will be included over two distinct 6-month periods (85 patients per period). Each period corresponds to the study of one fixation device: cord fixation or fixation with the AnchorFastTM medical device. The caregivers will also be included as a population since the workload with the two types of device will be evaluated and compared.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2024

First Posted

August 1, 2024

Study Start

August 2, 2024

Primary Completion (Estimated)

August 2, 2026

Study Completion (Estimated)

December 2, 2026

Last Updated

February 12, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations